 However, the dosage is adjusted by the prescribing clinician depending on factors such as severity of symptoms, patient age and response.Eperisone has not been established as definitely safe for paediatric use, therefore its use in paediatrics cannot be recommended without further study.If elderly patients are treated with eperisone, a reduced dose is recommended, and the patient should be closely monitored for signs of psychological hypofunction during treatment.